Valeant, an Aggressive Buyer of Drug Companies, Acquires Its Way to Mediocrity
Posted on June 20, 2011 at 15:33 PM EDT
Could Valeant be growing up, and in so doing turning into just another boring old drug company? Its numbers suggest that's exactly what's happening: It's acquiring its way to mediocrity.